Nasus Pharma Ltd. (NSRX) is a publicly traded the market company. As of July 28, 2026, NSRX trades at $3.05 with a market cap of $36.54M and a P/E ratio of 0.00. NSRX moved +0.00% today. Year to date, NSRX is -58.80%; over the trailing twelve months it is flat. Its 52-week range spans $1.98 to $9.99. Rallies surfaces NSRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NSRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.05 |
| Market Cap | $36.54M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.99 |
| 52-Week Low | $1.98 |
| Volume | 1.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
NSRX analyst coverage data. Average price target: $0.00.